Search Results
Breast Cancer Breakthrough - Professor Chris Lord on the OlympiA Trial
Olaparib improves disease-free survival in high-risk early-stage HER2-negative breast cancer wit...
OlympiA: adjuvant olaparib in gBRCAm, HER2-negative, high-risk, early breast cancer
OLYMPIA TRIAL LYNPARZA STOPS EARLY BREAST CANCER FROM COMING BACK
Perspectives on the OlympiA study of adjuvant olaparib in early breast cancer | Nadine Tung
Breast Cancer Breakthrough: Vaccine trials underway
UVA researchers discover breast cancer breakthrough that could help save lives
Dr. Tripathy on Impact of Olaparib Approval in BRCA-Positive Breast Cancer
Quality of life results from OlympiA
A Game-Changing Therapy for High-Risk Breast Cancers: An Interview with Susan M. Domchek, MD
How Breast Cancer Now helped discover PARP inhibitors
Clemson breast cancer study could save lives
